GlassScriptPhysician profile
Jerry Banks
NPI 1205179504
$700.09
in general payments reported to CMS, 2019-2025
13 companies · $249 in 2025
The $249 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $13.75 · 2024: $437 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $700.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $146.69 | 2024 | |
| Abbvie INC. | $145.96 | 2023-2024 | Linzess, Creon, Viberzi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.60 | 2024-2025 | Ofev |
| Glaxosmithkline, LLC. | $70.97 | 2024-2025 | Trelegy Ellipta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $66.10 | 2024-2025 | Xifaxan, Trulance |
| Sanofi Pasteur INC. | $41.60 | 2025 | |
| Lilly USA, LLC | $36.38 | 2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $24.24 | 2025 | Ozempic |
| Sanofi-Aventis U.S. LLC | $21.42 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $18.40 | 2024 | Farxiga |
| Pfizer INC. | $16.44 | 2025 | |
| Mylan Specialty L.P. | $14.42 | 2024 | Yupelri |
| Dexcom, INC. | $13.87 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Banks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.